131 related articles for article (PubMed ID: 14605126)
1. Novel enzyme-linked minisequence assay for genotypic analysis of human immunodeficiency virus type 1 drug resistance.
Sugiura W; Shimada K; Matsuda M; Chiba T; Myint L; Okano A; Yamada K
J Clin Microbiol; 2003 Nov; 41(11):4971-9. PubMed ID: 14605126
[TBL] [Abstract][Full Text] [Related]
2. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
[TBL] [Abstract][Full Text] [Related]
3. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F
New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549
[TBL] [Abstract][Full Text] [Related]
4. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
[TBL] [Abstract][Full Text] [Related]
5. [Study on genotypic resistance mutations to antiretroviral drugs on HIV strains of treated and treatment-naive HIV-1 infectious patients in Hubei province].
Wang XQ; Tong X; Tang H; Liu PP; Zhang W; Yang RG
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1112-5. PubMed ID: 18396668
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
[TBL] [Abstract][Full Text] [Related]
7. Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea.
Cho YK; Sung H; Ahn SH; Bae IG; Woo JH; Won YH; Kim DG; Kang MW
J Clin Microbiol; 2002 Apr; 40(4):1319-25. PubMed ID: 11923351
[TBL] [Abstract][Full Text] [Related]
8. Study of antiretroviral drug-resistant HIV-1 genotypes in northern Thailand: role of mutagenically separated polymerase chain reaction as a tool for monitoring zidovudine-resistant HIV-1 in resource-limited settings.
Saeng-Aroon S; Wichukchinda N; Myint L; Pathipvanich P; Ariyoshi K; Rojanawiwat A; Matsuda M; Sawanpanyalert P; Sugiura W; Auwanit W
J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1051-6. PubMed ID: 15247558
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.
Vega Y; Pérez-Alvárez L; Delgado E; Muñoz M; Casado G; Carmona R; Sierra M; Vázquez de Parga E; Pinilla M; García V; Medrano L; Contreras G; Thomson M; Nájera R
J Clin Microbiol; 2005 Oct; 43(10):5301-4. PubMed ID: 16208003
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.
Panos G; Charatsis G; Paparizos V; Kazantzi M; Falagas ME
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):43-51. PubMed ID: 18275347
[TBL] [Abstract][Full Text] [Related]
11. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil.
Cerqueira DM; Amorim RM; Silva RR; Camara GN; Brígido MM; Martins CR
Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):877-82. PubMed ID: 15761606
[TBL] [Abstract][Full Text] [Related]
13. Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1.
Myint L; Ariyoshi K; Yan H; Frater AJ; Auwanit W; Pathipvanith P; Yamada K; Matsuda M; Chiba T; Fujita K; McClure M; Weber JN; Sugiura W
Antimicrob Agents Chemother; 2002 Dec; 46(12):3861-8. PubMed ID: 12435689
[TBL] [Abstract][Full Text] [Related]
14. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
16. Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.
Tozzi V; Zaccarelli M; Narciso P; Trotta MP; Ceccherini-Silberstein F; De Longis P; D'Offizi G; Forbici F; D'Arrigo R; Boumis E; Bellagamba R; Bonfigli S; Carvelli C; Antinori A; Perno CF
J Infect Dis; 2004 May; 189(9):1688-95. PubMed ID: 15116307
[TBL] [Abstract][Full Text] [Related]
17. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Qari SH; Winters M; Vandamme AM; Merigan T; Heneine W
Antivir Ther; 2002 Jun; 7(2):131-9. PubMed ID: 12212925
[TBL] [Abstract][Full Text] [Related]
18. Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells.
Sarmati L; Nicastri E; Parisi SG; d'Ettorre G; Mancino G; Narciso P; Vullo V; Andreoni M
J Clin Microbiol; 2002 Feb; 40(2):335-40. PubMed ID: 11825939
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients.
Re MC; Monari P; Bon I; Gibellini D; Vitone F; Borderi M; La Placa M
BMC Microbiol; 2001; 1():30. PubMed ID: 11737863
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China.
Tu YQ; Wang MJ; Yao J; Zhu XM; Pan PL; Xing WG; Zhang GH; Yang RG; Zheng YT; Jiang Y
Transfusion; 2009 Sep; 49(9):1865-73. PubMed ID: 19453981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
